CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation. EINPresswire/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has ...

Eight breakthrough technologies that are redefining how we discover drugs, deliver care, and create a more connected and ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...

Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses. CRISPR/Cas systems, originally derived from bacterial immune responses, ...

Advancements in gene-editing technology are propelling xenotransplantation, potentially addressing organ shortage with pig organs modified for human compatibility.